SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 546 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,552 | +664.7% | 469,249 | +593.7% | 0.30% | +662.5% |
| Q2 2023 | $13,019 | +0.6% | 67,644 | +5.8% | 0.04% | -11.1% |
| Q1 2023 | $12,942 | -57.2% | 63,919 | -72.8% | 0.04% | -58.3% |
| Q4 2022 | $30,230 | -99.8% | 235,233 | +122.8% | 0.11% | +89.5% |
| Q3 2022 | $14,448,000 | -34.3% | 105,591 | -15.1% | 0.06% | -32.1% |
| Q2 2022 | $21,994,000 | -0.5% | 124,303 | -19.0% | 0.08% | +9.1% |
| Q1 2022 | $22,099,000 | +24.8% | 153,413 | +33.9% | 0.08% | +30.5% |
| Q4 2021 | $17,709,000 | +89.7% | 114,545 | +108.4% | 0.06% | +68.6% |
| Q3 2021 | $9,333,000 | +1028.5% | 54,969 | +948.8% | 0.04% | +1066.7% |
| Q2 2021 | $827,000 | +16.0% | 5,241 | +2.1% | 0.00% | 0.0% |
| Q1 2021 | $713,000 | -23.7% | 5,134 | -3.7% | 0.00% | -25.0% |
| Q4 2020 | $934,000 | – | 5,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |